Hypertension Diagnostics Probability of Future Pink Sheet Price Finishing Under 0.0029

HDIIDelisted Stock  USD 0  0.0008  38.10%   
Hypertension Diagnostics' future price is the expected price of Hypertension Diagnostics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Hypertension Diagnostics performance during a given time horizon utilizing its historical volatility. Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
  
Please specify Hypertension Diagnostics' target price for which you would like Hypertension Diagnostics odds to be computed.

Hypertension Diagnostics Target Price Odds to finish below 0.0029

The tendency of Hypertension Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move below current price in 90 days
 0 90 days 0 
about 54.12
Based on a normal probability distribution, the odds of Hypertension Diagnostics to move below current price in 90 days from now is about 54.12 (This Hypertension Diagnostics probability density function shows the probability of Hypertension Pink Sheet to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Hypertension Diagnostics has a beta of -0.85. This usually indicates Moreover Hypertension Diagnostics has an alpha of 1.6035, implying that it can generate a 1.6 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Hypertension Diagnostics Price Density   
       Price  

Predictive Modules for Hypertension Diagnostics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Hypertension Diagnostics. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.0000.00
Details
Intrinsic
Valuation
LowRealHigh
0.0000.00
Details

Hypertension Diagnostics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Hypertension Diagnostics is not an exception. The market had few large corrections towards the Hypertension Diagnostics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Hypertension Diagnostics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Hypertension Diagnostics within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
1.60
β
Beta against Dow Jones-0.85
σ
Overall volatility
0.0006
Ir
Information ratio 0.09

Hypertension Diagnostics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Hypertension Diagnostics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Hypertension Diagnostics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Hypertension Diagnostics is not yet fully synchronised with the market data
Hypertension Diagnostics has some characteristics of a very speculative penny stock
Hypertension Diagnostics has a very high chance of going through financial distress in the upcoming years
Hypertension Diagnostics currently holds 4.69 M in liabilities. Hypertension Diagnostics has a current ratio of 0.51, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Hypertension Diagnostics until it has trouble settling it off, either with new capital or with free cash flow. So, Hypertension Diagnostics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Hypertension Diagnostics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Hypertension to invest in growth at high rates of return. When we think about Hypertension Diagnostics' use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 3.79 M. Net Loss for the year was (125.39 K) with profit before overhead, payroll, taxes, and interest of 954.47 K.
Hypertension Diagnostics currently holds about 5.66 K in cash with (389.28 K) of positive cash flow from operations.

Hypertension Diagnostics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Hypertension Pink Sheet often depends not only on the future outlook of the current and potential Hypertension Diagnostics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Hypertension Diagnostics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding52.4 M

Hypertension Diagnostics Technical Analysis

Hypertension Diagnostics' future price can be derived by breaking down and analyzing its technical indicators over time. Hypertension Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Hypertension Diagnostics. In general, you should focus on analyzing Hypertension Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

Hypertension Diagnostics Predictive Forecast Models

Hypertension Diagnostics' time-series forecasting models is one of many Hypertension Diagnostics' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Hypertension Diagnostics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about Hypertension Diagnostics

Checking the ongoing alerts about Hypertension Diagnostics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Hypertension Diagnostics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Hypertension Diagnostics is not yet fully synchronised with the market data
Hypertension Diagnostics has some characteristics of a very speculative penny stock
Hypertension Diagnostics has a very high chance of going through financial distress in the upcoming years
Hypertension Diagnostics currently holds 4.69 M in liabilities. Hypertension Diagnostics has a current ratio of 0.51, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Hypertension Diagnostics until it has trouble settling it off, either with new capital or with free cash flow. So, Hypertension Diagnostics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Hypertension Diagnostics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Hypertension to invest in growth at high rates of return. When we think about Hypertension Diagnostics' use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 3.79 M. Net Loss for the year was (125.39 K) with profit before overhead, payroll, taxes, and interest of 954.47 K.
Hypertension Diagnostics currently holds about 5.66 K in cash with (389.28 K) of positive cash flow from operations.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Consideration for investing in Hypertension Pink Sheet

If you are still planning to invest in Hypertension Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hypertension Diagnostics' history and understand the potential risks before investing.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments